Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DOW DOW	$28.38 -1.2%	$28.99	$25.06 ▼ $55.97	$20.31B	0.89	7.36 million shs	5.95 million shs
DOW DOW	$28.38 -1.2%	$28.99	$25.06 ▼ $55.97	$20.31B	0.89	7.36 million shs	5.95 million shs
PFE Pfizer	$25.45 +0.5%	$23.67	$20.92 ▼ $31.54	$143.95B	0.58	41.63 million shs	27.10 million shs
VZ Verizon Communications	$43.62 +0.1%	$43.19	$37.59 ▼ $47.36	$183.79B	0.37	20.12 million shs	10.30 million shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DOW DOW	-1.05%	+4.00%	+2.16%	+0.62%	-46.33%
DOW DOW	-1.05%	+4.00%	+2.16%	+0.62%	-46.33%
PFE Pfizer	+0.49%	+4.69%	+8.89%	+10.68%	-8.04%
VZ Verizon Communications	+0.09%	+3.58%	-0.56%	+1.19%	+6.11%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
DOW DOW	3.8171 of 5 stars	3.0	4.0	1.7	0.0	1.4	1.7	2.5
DOW DOW	3.8171 of 5 stars	3.0	4.0	1.7	0.0	1.4	1.7	2.5
PFE Pfizer	4.976 of 5 stars	3.2	3.0	4.2	4.5	2.8	1.7	3.1
VZ Verizon Communications	4.4502 of 5 stars	1.3	2.0	5.0	3.5	3.4	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DOW DOW	2.06	Hold	$33.65	18.56% Upside
DOW DOW	2.06	Hold	$33.65	18.56% Upside
PFE Pfizer	2.45	Hold	$28.55	12.20% Upside
VZ Verizon Communications	2.59	Moderate Buy	$47.25	8.32% Upside

Current Analyst Ratings Breakdown

Latest DOW, VZ, PFE, and DOW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/3/2025	DOW DOW	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$32.00 ➝ $30.00
7/3/2025	DOW DOW	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$32.00 ➝ $30.00
6/25/2025	DOW DOW	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		$35.00 ➝ $33.00
6/25/2025	DOW DOW	Vertical Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		$35.00 ➝ $33.00
6/23/2025	DOW DOW	Fermium Researc Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
6/23/2025	DOW DOW	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Market Perform ➝ Underperform	$29.00 ➝ $22.00
6/23/2025	DOW DOW	Fermium Researc Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
6/23/2025	DOW DOW	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Market Perform ➝ Underperform	$29.00 ➝ $22.00
5/29/2025	PFE Pfizer	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	$28.00 ➝ $25.00
5/22/2025	DOW DOW	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Market Perform ➝ Underperform
5/22/2025	DOW DOW	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Market Perform ➝ Underperform

(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DOW DOW	$42.63B	0.47	$5.77 per share	4.92	$25.36 per share	1.12
DOW DOW	$42.63B	0.47	$5.77 per share	4.92	$25.36 per share	1.12
PFE Pfizer	$62.46B	2.32	$4.39 per share	5.80	$15.62 per share	1.63
VZ Verizon Communications	$134.79B	1.36	$8.87 per share	4.92	$23.89 per share	1.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DOW DOW	$1.12B	$0.40	70.95	9.75	10.89	0.69%	4.59%	1.44%	7/24/2025 (Estimated)
DOW DOW	$1.12B	$0.40	70.95	9.75	10.89	0.69%	4.59%	1.44%	7/24/2025 (Estimated)
PFE Pfizer	$8.03B	$1.38	18.44	8.40	0.92	12.62%	20.33%	8.53%	8/5/2025 (Estimated)
VZ Verizon Communications	$17.51B	$4.20	10.39	8.98	3.23	13.14%	19.66%	5.13%	7/21/2025 (Estimated)

Latest DOW, VZ, PFE, and DOW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/24/2025	Q2 2025	DOW DOW	-$0.01	N/A	N/A	N/A	$10.38 billion	N/A
7/24/2025	Q2 2025	DOW DOW	-$0.01	N/A	N/A	N/A	$10.38 billion	N/A
7/21/2025	Q2 2025	VZ Verizon Communications	$1.18	N/A	N/A	N/A	$33.47 billion	N/A
4/29/2025	Q1 2025	PFE Pfizer	$0.67	$0.92	+$0.25	$0.52	$14.43 billion	$13.72 billion
4/24/2025	Q1 2025	DOW DOW	-$0.01	$0.02	+$0.03	-$0.44	$10.31 billion	$10.43 billion
4/24/2025	Q1 2025	DOW DOW	-$0.01	$0.02	+$0.03	-$0.44	$10.31 billion	$10.43 billion
4/22/2025	Q1 2025 Pre Recorded	VZ Verizon Communications	$1.15	$1.19	+$0.04	$1.16	$33.31 billion	$33.50 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
DOW DOW	$2.80	9.87%	N/A	700.00%	N/A
DOW DOW	$2.80	9.87%	N/A	700.00%	N/A
PFE Pfizer	$1.72	6.76%	N/A	124.64%	16 Years
VZ Verizon Communications	$2.71	6.21%	N/A	64.52%	20 Years

Latest DOW, VZ, PFE, and DOW Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/25/2025	PFE Pfizer	quarterly	$0.43	7.08%	7/25/2025	7/25/2025	9/2/2025
6/6/2025	VZ Verizon Communications	quarterly	$0.6775	6.22%	7/10/2025	7/10/2025	8/1/2025
4/11/2025	DOW DOW	quarterly	$0.70	9.9%	5/30/2025	5/30/2025	6/13/2025
4/11/2025	DOW DOW	quarterly	$0.70	9.9%	5/30/2025	5/30/2025	6/13/2025
4/23/2025	PFE Pfizer	quarterly	$0.43	7.69%	5/9/2025	5/9/2025	6/13/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DOW DOW	0.92	1.54	0.90
DOW DOW	0.92	1.54	0.90
PFE Pfizer	0.64	1.26	0.96
VZ Verizon Communications	1.19	0.61	0.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DOW DOW	64.00%
DOW DOW	64.00%
PFE Pfizer	68.36%
VZ Verizon Communications	62.06%

Insider Ownership

Company	Insider Ownership
DOW DOW	0.50%
DOW DOW	0.50%
PFE Pfizer	0.06%
VZ Verizon Communications	0.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DOW DOW	36,000	706.86 million	703.33 million	Optionable
DOW DOW	36,000	706.86 million	703.33 million	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable
VZ Verizon Communications	99,600	4.22 billion	4.21 billion	Optionable

DOW, VZ, PFE, and DOW Headlines

Recent News About These Companies

Revisor Wealth Management LLC Makes New Investment in Verizon Communications Inc. (NYSE:VZ)

1 hour ago | marketbeat.com

Verizon Leaks Google Pixel's July 2025 Update: Here's What Includes

July 3 at 12:45 AM | msn.com

Verizon Denied $22 Million Tax Refund at Rhode Island High Court

July 3 at 12:45 AM | news.bloomberglaw.comN

Why Verizon Communications (VZ) is a Top Momentum Stock for the Long-Term

July 3 at 10:51 AM | zacks.com

North Capital Inc. Invests $690,000 in Verizon Communications Inc. (NYSE:VZ)

July 3 at 9:03 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Bought by D.A. Davidson & CO.

July 3 at 9:02 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Sold by Xcel Wealth Management LLC

July 3 at 8:27 AM | marketbeat.com

Mutual Advisors LLC Has $5.77 Million Stock Position in Verizon Communications Inc. (NYSE:VZ)

July 3 at 8:25 AM | marketbeat.com

ZWJ Investment Counsel Inc. Buys 41,989 Shares of Verizon Communications Inc. (NYSE:VZ)

July 3 at 7:56 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Sold by Teacher Retirement System of Texas

July 3 at 7:29 AM | marketbeat.com

First Horizon Advisors Inc. Has $41.28 Million Stock Holdings in Verizon Communications Inc. (NYSE:VZ)

July 3 at 7:08 AM | marketbeat.com

Verizon Communications Inc. (NYSE:VZ) Shares Sold by Keybank National Association OH

July 3 at 5:19 AM | marketbeat.com

Last Chance: Get a new phone for $1,000 off on any Verizon myPlan account, no trade-in

July 2 at 11:04 PM | androidauthority.comA

VZ - Verizon Communications Inc Chart - Morningstar

July 2 at 6:03 PM | morningstar.comM

July Dog Of The Dow's 'Safer' Buy: Verizon

July 2 at 6:03 PM | seekingalpha.com

Verizon Gains 9.2% YTD: Should You Invest in VZ Stock Now?

July 2 at 12:41 PM | zacks.com

Should You Invest In Your Mobile Provider? Why Verizon and AT&T Are Good Picks

July 2 at 12:34 PM | msn.com

Investors Heavily Search Verizon Communications Inc. (VZ): Here is What You Need to Know

July 2 at 10:00 AM | zacks.com

Miller Howard Investments Inc. NY Purchases Shares of 1,380,512 Verizon Communications Inc. (NYSE:VZ)

July 2 at 9:52 AM | marketbeat.com

Kanawha Capital Management LLC Has $10.36 Million Stock Holdings in Verizon Communications Inc. (NYSE:VZ)

July 2 at 8:52 AM | marketbeat.com

61 million Verizon records reportedly for sale — including date of birth, tax ID and phone numbers

July 1 at 12:23 AM | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Addition by Subtraction: Intel’s New Strategy Energizes Investors
By Jeffrey Neal Johnson | June 27, 2025
View Addition by Subtraction: Intel’s New Strategy Energizes Investors
Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
By Jeffrey Neal Johnson | June 17, 2025
View Analyst Downgrades Joby, But Overlooks Major Regulatory Wins
Tankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names
By Leo Miller | June 10, 2025
View Tankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names
Dollar Down 10%? These 3 Stocks Could Soar
By Chris Markoch | July 1, 2025
View Dollar Down 10%? These 3 Stocks Could Soar
Costco at a Crossroads: Is the Next Move Higher or Lower?
By Dan Schmidt | June 25, 2025
View Costco at a Crossroads: Is the Next Move Higher or Lower?

DOW, VZ, PFE, and DOW Company Descriptions

DOW NYSE:DOW

$28.38 -0.35 (-1.22%)

Closing price 07/3/2025 03:57 PM Eastern

Extended Trading

$28.48 +0.11 (+0.37%)

As of 07/3/2025 04:56 PM Eastern

Dow, Inc. is a materials science company, which engages in the development of innovative solutions. It operates through the following segments: Packaging and Specialty Plastics, Industrial Intermediates and Infrastructure, and Performance Materials and Coatings. The Packaging and Specialty Plastics segment consists of hydrocarbons and energy and packaging and specialty plastics. The Industrial Intermediates and Infrastructure segment covers the industrial solutions and polyurethanes and construction chemicals. The Performance Materials and Coatings segment includes coatings and performance monomers and consumer solutions. The company was founded in 1897 and is headquartered in Midland, MI.

DOW NYSE:DOW

$28.38 -0.35 (-1.22%)

Closing price 07/3/2025 03:57 PM Eastern

Extended Trading

$28.48 +0.11 (+0.37%)

As of 07/3/2025 04:56 PM Eastern

Pfizer NYSE:PFE

$25.44 +0.13 (+0.49%)

Closing price 07/3/2025 03:59 PM Eastern

Extended Trading

$25.42 -0.03 (-0.11%)

As of 07/3/2025 05:00 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Verizon Communications NYSE:VZ

$43.62 +0.03 (+0.07%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$43.64 +0.02 (+0.05%)

As of 07/3/2025 04:59 PM Eastern

Verizon Communications Inc., through its subsidiaries, engages in the provision of communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide. It operates in two segments, Verizon Consumer Group (Consumer) and Verizon Business Group (Business). The Consumer segment provides wireless services across the wireless networks in the United States under the Verizon and TracFone brands and through wholesale and other arrangements; and fixed wireless access (FWA) broadband through its wireless networks, as well as related equipment and devices, such as smartphones, tablets, smart watches, and other wireless-enabled connected devices. The segment also offers wireline services in the Mid-Atlantic and Northeastern United States, as well as Washington D.C. through its fiber-optic network, Verizon Fios product portfolio, and a copper-based network. The Business segment provides wireless and wireline communications services and products, including FWA broadband, data, video and conferencing, corporate networking, security and managed network, local and long-distance voice, and network access services to deliver various IoT services and products to businesses, government customers, and wireless and wireline carriers in the United States and internationally. The company was formerly known as Bell Atlantic Corporation and changed its name to Verizon Communications Inc. in June 2000. Verizon Communications Inc. was incorporated in 1983 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time